Product search
Filter
Search results
CRYOcheck Chromogenic Factor IX
This chromogenic assay is intended to be used as an aid in the management of hemophilia B in individuals aged two years or older. With a limit of quantification of 0.7% FIX activity and a test range of 0–200% FIX CRYO check Chromogenic Factor IX provides unsurpassed assurance in results, especially in cases of patients with severe hemophilia B.
BIOPHEN Factor VIII (bovine reagent R1)
Diagnosis of congenital or acquired FVIII deficiencies (hemophilia A) Follow-up of FVIII recovery in treated patients (exceptemicizumab) Factor VIII inhibitor assay in presence oemicizumab Measurement of high FVIII concentrations
Factor IX deficient plasma congenital (frozen)
For all in-vitro -analyses that require congenital human factor IX deficient plasma.
LIAPHEN™ Protein C
Quantitative determination of protein C antigen in human citrated plasma.
5-ELISA ADAMTS-13 Antigen
Measurement of ADAMTS-13 antigen in human plasma by one-step method or two-step method.
CRYOcheck Factor VIII Deficient Plasma with VWF, frozen
Intended for use as a deficient substrate in clot-based factor VIII activity assays using the one-stage activated partial thromboplastin time (aPTT) method.
CRYOcheck Factor VIII Deficient Plasma with VWF, frozen
Intended for use as a deficient substrate in clot-based factor VIII activity assays using the one-stage activated partial thromboplastin time (aPTT) method.
TRAP-6
HEMOCLOT Protein C
Diagnosis of congenital or acquired protein C deficiencies. Protein C concentrates.
PT-Phen™ LRT
Determination of prothrombin time (PT) in human citrated plasma with ready-for-use liquid reagents.